2.Epithelial borderline ovarian tumor: Diagnosis and treatment strategy.
Kimio USHIJIMA ; Kouichiro KAWANO ; Naotake TSUDA ; Shin NISHIO ; Atsumu TERADA ; Hiroyuki KATO ; Kazuto TASAKI ; Ken MATSUKUMA
Obstetrics & Gynecology Science 2015;58(3):183-187
Epithelial borderline ovarian tumors (BOT) are distinctive from benign tumors and carcinoma. They occur in younger women more often than carcinoma, and there is some difficulty making correct diagnosis of BOT. Two subtypes of BOT, serous and mucinous borderline tumor have different characteristics and very different clinical behavior. Serous borderline tumor (SBT) with micropapillary pattern shows more incidence of extra ovarian disease and often coexists with invasive implant. SBT with micropapillary pattern in advanced stage has showed a worse prognosis than typical SBT. Huge mucinous borderline tumors have histologic heterogeneity, and the accuracy of frozen section diagnosis is relatively low. Extensive sampling is required to reach a correct pathological diagnosis. Mucinous adenoma (intestinal type) also runs the risk of recurrence after cystectomy, or intraoperative rupture of cyst. Laparoscopic procedure for BOT has not increased the risk of recurrence. Fertility preserving procedures are generally accepted, except in advanced stage SBT with invasive implants. Only cystectomy shows a significant risk of recurrence. Re-staging surgery and full staging surgery is not necessary for all BOT. We should not attempt to treat them uniformly, by the single diagnosis of "borderline tumor". It depends on histologic type. Close communication with the pathologist is necessary to gain more detail and ask more pathological samples in order to make the optimal treatment strategy for each individual patients.
Adenoma
;
Cystectomy
;
Diagnosis*
;
Female
;
Fertility
;
Frozen Sections
;
Humans
;
Incidence
;
Laparoscopy
;
Mucins
;
Ovarian Diseases
;
Population Characteristics
;
Prognosis
;
Recurrence
;
Rupture
3.Epithelial borderline ovarian tumor: Diagnosis and treatment strategy.
Kimio USHIJIMA ; Kouichiro KAWANO ; Naotake TSUDA ; Shin NISHIO ; Atsumu TERADA ; Hiroyuki KATO ; Kazuto TASAKI ; Ken MATSUKUMA
Obstetrics & Gynecology Science 2015;58(3):183-187
Epithelial borderline ovarian tumors (BOT) are distinctive from benign tumors and carcinoma. They occur in younger women more often than carcinoma, and there is some difficulty making correct diagnosis of BOT. Two subtypes of BOT, serous and mucinous borderline tumor have different characteristics and very different clinical behavior. Serous borderline tumor (SBT) with micropapillary pattern shows more incidence of extra ovarian disease and often coexists with invasive implant. SBT with micropapillary pattern in advanced stage has showed a worse prognosis than typical SBT. Huge mucinous borderline tumors have histologic heterogeneity, and the accuracy of frozen section diagnosis is relatively low. Extensive sampling is required to reach a correct pathological diagnosis. Mucinous adenoma (intestinal type) also runs the risk of recurrence after cystectomy, or intraoperative rupture of cyst. Laparoscopic procedure for BOT has not increased the risk of recurrence. Fertility preserving procedures are generally accepted, except in advanced stage SBT with invasive implants. Only cystectomy shows a significant risk of recurrence. Re-staging surgery and full staging surgery is not necessary for all BOT. We should not attempt to treat them uniformly, by the single diagnosis of "borderline tumor". It depends on histologic type. Close communication with the pathologist is necessary to gain more detail and ask more pathological samples in order to make the optimal treatment strategy for each individual patients.
Adenoma
;
Cystectomy
;
Diagnosis*
;
Female
;
Fertility
;
Frozen Sections
;
Humans
;
Incidence
;
Laparoscopy
;
Mucins
;
Ovarian Diseases
;
Population Characteristics
;
Prognosis
;
Recurrence
;
Rupture
4.Antiplatelet Therapy May Be Insufficient to Prevent Stroke Recurrence Before Percutaneous Patent Foramen Ovale Closure
Hiroyuki KAWANO ; Yuko HONDA ; Takashi JOHNO ; Hibiku MARUOKA ; Kaoru NAKANISHI ; Mikito SAITO ; Kensuke OGATA ; Atsushi YAMAMICHI ; Ayane KAWATAKE ; Teruyuki HIRANO
Journal of Stroke 2023;25(2):307-310
5.A Comprehensive Study of Outcome of Bilateral Cataract Surgery Performed on Patients Living on Remote Islands, Postoperative Management at their Homes and Postoperative Complications
Koji KAWAMOTO ; Yumiko YAMASHITA ; Mitsue KAWANO ; Kayoko YASUI ; Misato OKAIRI ; Miho NOMURA ; Kyouko SAGAWA ; Ayako FUJII ; Yoko IWASHIGE ; Miyuki OKAMURA ; Hiroki OKIDA ; Makoto KENJO ; Makoto FUJIKAWA ; Miho NINOMIYA ; Hiroyuki TANAKA ; Takahiko KUBO ; Hiroyuki NISHIHARA ; Toru HAYASHI ; Jyunichi MURAKAMI
Journal of the Japanese Association of Rural Medicine 2010;59(4):493-499
Purpose: We examined the safety and efficacy of cataract surgery and postoperative management in our hospital and at the homes of the patients who live on medically underserved remote.
Patients and methods: A total of 27 patients (54 eyes), who were followed in our hospital or at their homes were enrolled in this study. Cataract surgery was performed on them between January 2009 and January 2010 and we could follow up six months postoperatively. We divided these patients into two groups:group I (GI) consisted of 13 patients who could come to our hospital regularly during both preoperative and postoperative periods, and group II (GII) consisted of 14 patients who could not come to our hospital regularly during either preoperative or postoperative periods. Cataract surgeries were performed on all the patients in GI and GII in our hospital. The patients in GI were hospitalized for three days and those in GII were for seven days. After cataract surgery, the patients in GI had their eyes checked regularly in our hospital and those in GII were in their homes where the doctor visited. Postoperative ophthalmic clinical tests were conducted to examine visual acuity, intraocular pressure and fundus.
Results: GI comprised three males and 10 females. Their age averaged 79.3. GII comprised four males and 10 females. Their age averaged 82.6. Preoperative ophthalmic examinations found that preoperative average visual acuity (LogMAR and decimal visual acuity in parentheses) and spherical equivalent in GI and GII were 0.69 (0.41), 0.80 (0.33) and -0.43 dioptors, -0.42 dioptors respectively, showing no significant differences between the two groups. Postoperative ophthalmic examinations found that, best corrected visual acuity (LogMAR) was significantly increased to 0.36 (0.66) and 0.44 (0.53) in GI and GII respectively, showing no significant differences either.
Conclusions: We concluded that we could get safe and efficient cataract surgery and postoperative management combined with prolonged hospitalization and house calls on the patients who live in the isolated islands.
6.Visibility of CT Early Ischemic Change Is Significantly Associated with Time from Stroke Onset to Baseline Scan beyond the First 3 Hours of Stroke Onset.
Jian GAO ; Mark W PARSONS ; Hiroyuki KAWANO ; Christopher R LEVI ; Tiffany Jane EVANS ; Longting LIN ; Andrew BIVARD
Journal of Stroke 2017;19(3):340-346
BACKGROUND AND PURPOSE: Non-contrast brain computed tomography (NCCT) remains the most common imaging modality employed to select patients for thrombolytic therapy in acute ischemic stroke. The current study used the Alberta Stroke Program Early CT Score (ASPECTS) to identify early ischemic changes on brain NCCT imaging with the aim to investigate whether a relationship exists between time from symptoms onset to NCCT with the presence of early ischaemic change quantified by ASPECTS. METHODS: We studied 1,329 ischemic stroke patients who had NCCT within 8 hours of stroke onset. Patients were assessed to see if they had any ASPECTS lesion and if the rate of patients with a lesion increased with time using logistic regression. RESULTS: 30% patients had an ASPECTS < 10 within the first 3 hours from symptom onset. Within the first 3 hours, the odds for a CT change (ASPECTS < 10) per minute of time was 1.00 with 95% confidence interval (CI) (0.99 to 1.00) (P=0.266). After 3 hours, there was a significant increase in odds of ASPECTS < 10 with increasing time. The odds of being ASPECTS positive increased 1% (odds ratio=1.01) per 1 minute of time with 95% CI (1.00 to 1.01) (P=0.002). CONCLUSIONS: We have identified that prior to first 3 hours of stroke there was no effect of time on odds of CT ischemic change; after the first 3 hours of stroke the odds increased with increasing time to CT scan. The occurrence of early ischemic change may be a marker of time from stroke onset rather than severity.
Alberta
;
Brain
;
Humans
;
Logistic Models
;
Stroke*
;
Thrombolytic Therapy
;
Tomography, X-Ray Computed
7.Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study.
Yoshiyasu KONO ; Hiroyuki OKADA ; Ryuta TAKENAKA ; Ko MIURA ; Hiromitsu KANZAKI ; Keisuke HORI ; Masahide KITA ; Takao TSUZUKI ; Seiji KAWANO ; Yoshiro KAWAHARA ; Kazuhide YAMAMOTO
Gut and Liver 2016;10(1):69-75
BACKGROUND/AIMS: The interaction between nonsteroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori remains controversial. We retrospectively investigated whether H. pylori infection exacerbates severe gastric mucosal injury among chronic NSAID users. METHODS: From January 2010 to December 2013, a total of 245 long-term NSAID (including low-dose aspirin) users who had undergone an esophagogastroduodenoscopy and had been evaluated for H. pylori infection were enrolled at Okayama University Hospital and Tsuyama Chuo Hospital. The degree of gastric mucosal injury was assessed according to the modified Lanza score (MLS). Severe gastric mucosal injury was defined as an MLS > or =4. Univariate and multivariate logistic regression analyses were performed. RESULTS: In the univariate analysis, age > or =75 years (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.3 to 4.2), H. pylori-positivity (OR, 2.0; 95% CI, 1.2 to 3.5), and the concomitant use of proton pump inhibitors (PPIs) (OR, 0.48; 95% CI, 0.26 to 0.86) were significantly associated with severe gastric mucosal injury. The multivariate analysis was adjusted by age and sex and demonstrated that H. pylori-positivity (OR, 1.8; 95% CI, 1.0 to 3.3) and the concomitant use of PPIs (OR, 0.53; 95% CI, 0.28 to 0.99) significantly contributed to severe gastric mucosal injury. CONCLUSIONS: H. pylori infection exacerbates severe gastric mucosal injury among chronic NSAID users.
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/*adverse effects
;
Case-Control Studies
;
*Disease Progression
;
Endoscopy, Digestive System
;
Female
;
Gastric Mucosa/*drug effects/*microbiology
;
Helicobacter Infections/*complications/microbiology/pathology
;
*Helicobacter pylori/drug effects
;
Humans
;
Logistic Models
;
Male
;
Middle Aged
;
Odds Ratio
;
Proton Pump Inhibitors/adverse effects
;
Retrospective Studies
8.Postoperative Bleeding Risk after Gastric Endoscopic Submucosal Dissection in Patients Receiving a P2Y12 Receptor Antagonist
Ryosuke HIRAI ; Seiji KAWANO ; Shoko INOO ; Sakiko KURAOKA ; Shotaro OKANOUE ; Takuya SATOMI ; Kenta HAMADA ; Yoshiyasu KONO ; Hiromitsu KANZAKI ; Masaya IWAMURO ; Yoshiro KAWAHARA ; Hiroyuki OKADA
Gut and Liver 2023;17(3):404-411
Background/Aims:
The safety of gastric endoscopic submucosal dissection (ESD) in users of a P2Y12 receptor antagonist (P2Y12RA) under current guidelines has not been verified.
Methods:
Patients treated by gastric ESD at Okayama University Hospital between January 2013 and December 2020 were registered. The postoperative bleeding rates of patients (group A) who did not receive any antithrombotic drugs; patients (group B) receiving aspirin or cilostazol monotherapy; and P2Y12RA users (group C) those on including monotherapy or dual antiplatelet therapy were compared. The risk factors for post-ESD bleeding were examined in a multivariate analysis of patient background, tumor factors, and antithrombotic drug management.
Results:
Ultimately, 1,036 lesions (847 patients) were enrolled. The bleeding rates of group B and C were significantly higher than that of group A (p=0.012 and p<0.001, respectively), but there was no significant difference between group B and C (p=0.11). The postoperative bleeding rate was significantly higher in dual antiplatelet therapy than in P2Y12RA monotherapy (p=0.014). In multivariate analysis, tumor diameter ≥12 mm (odds ratio [OR], 4.30; 95% confidence interval [CI], 1.99 to 9.31), anticoagulant use (OR, 4.03; 95% CI, 1.64 to 9.86), and P2Y12RA use (OR, 3.40; 95% CI, 1.07 to 10.70) were significant risk factors for postoperative bleeding.
Conclusions
P2Y12RA use is a risk factor for postoperative bleeding in patients who undergo ESD even if receiving drug management according to guidelines. Dual antiplatelet therapy carries a higher risk of bleeding than monotherapy.
9.Effects of combined therapy of alendronate and low-intensity pulsed ultrasound on metaphyseal bone repair after osteotomy in the proximal tibia of glucocorticoid-induced osteopenia rats.
Tetsuya KAWANO ; Naohisa MIYAKOSHI ; Yuji KASUKAWA ; Michio HONGO ; Hiroyuki TSUCHIE ; Chie SATO ; Masashi FUJII ; Masazumi SUZUKI ; Manabu AKAGAWA ; Yuichi ONO ; Yusuke YUASA ; Itsuki NAGAHATA ; Yoichi SHIMADA
Osteoporosis and Sarcopenia 2017;3(4):185-191
OBJECTIVES: Glucocorticoid (GC) treatment inhibits activation of runt-related transcription factor 2 (Runx2), which is essential for osteoblast differentiation from stem cells. As a result, GC treatment results in bone loss, GC-induced osteoporosis (GIO), elevated fracture risk, and delayed bone healing. Bisphosphonates such as alendronate (ALN) are recommended for treating or preventing GIO, and lowintensity pulsed ultrasound (LIPUS) facilitates fracture healing and maturation of regenerated bone. Combined therapy with ALN and LIPUS may stimulate cancellous bone healing in GIO rats. Here, we examined the effect of ALN and LIPUS on cancellous bone osteotomy repair in the proximal tibia of GIO rats. METHODS: Prednisolone (10 mg/kg body weight/day) was administered for 4 weeks to induce GIO in 6-month-old female Sprague-Dawley rats. Tibial osteotomy was then performed and daily subcutaneous injection of ALN (1-µg/kg body weight) was subsequently administered alone or in combination with LIPUS (20 min/day) for 2 or 4 weeks. RESULTS: ALN significantly increased bone mineral density (BMD) at 2 and 4 weeks, and ALN + LIPUS significantly increased BMD at 4 weeks. Bone union rates were significantly increased after 2 and 4 weeks ALN and ALN + LIPUS treatment. Lastly, ALN and ALN + LIPUS significantly increased the proportion of Runx2 positive cells at 4 weeks. CONCLUSIONS: ALN monotherapy and combined ALN and LUPUS treatment augmented BMD and stimulated cancellous bone repair with increased Runx2 expression at the osteotomy site in GIO rats. However, the combined treatment had no additional effect on cancellous bone healing compared to ALN monotherapy.
Alendronate*
;
Animals
;
Bone Density
;
Bone Diseases, Metabolic*
;
Diphosphonates
;
Female
;
Fracture Healing
;
Humans
;
Infant
;
Injections, Subcutaneous
;
Osteoblasts
;
Osteoporosis
;
Osteotomy*
;
Prednisolone
;
Rats*
;
Rats, Sprague-Dawley
;
Stem Cells
;
Tibia*
;
Transcription Factors
;
Ultrasonic Waves*